Search
Now showing items 1-4 of 4
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial
Wissenschaftlicher Artikel
(Universität Ulm, 2013)
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
Wissenschaftlicher Artikel
(Universität Ulm, 2010)
Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial
Wissenschaftlicher Artikel
(Universität Ulm, 2017)
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
Wissenschaftlicher Artikel
(Universität Ulm, 2017)